TuncayDelibasiMD

Diabetes, Obesity, Thyroid

Medical Geneticist

Dr. Delibasi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

He has published hundreds of journal papers and book chapters and scientific papers including more than 100 teaching presentations. He also serves as a reviewer in numerous journals. Furthermore, he received many research grants on the endocrine system, genetics, obesity, as well as stem cells.

Metabolic syndrome, Hypertension, Familial hypercholesterolemia, Insulinoma, Type I diabetes mellitus, Type II diabetes mellitus, Obesity and obesity-related disorders, Diabetes, Clinical genetics, Endocrinology, Metabolic and endocrine disorders, Thyroid cancer, Medical genetics, Stem cell transplantation, Internal medicine, Insulin resistance, Pituitary disease, Adrenal disease, Continuous glucose monitoring, Thyroid diseases

University of Texas Southwestern Medical CenterResidency, Medical Genetics and Genomics, 2020 - 2022
UCLA, Pharmacogenomics and Clinical Pharmacology, Reseacrh FellowshipMD, 2004 - 2006
Ankara University, Endocrinology FellowshipMD, 2000 - 2003
Ankara Numune Hospital, Internal Medicine ResidencyMD, 1993 - 1998
Hacettepe University FOMClass of 1993

PubMed

15 citations
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.
André Lacroix, Marcello D. Bronstein, Jochen Schopohl, T. Delibasi, Roberto Salvatori
Journal of Endocrinological Investigation. 2020-05-08
36 citations
Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS
Neha J. Pagidipati, Yinggan Zheng, Jennifer B. Green, Darren K. McGuire, Robert J. Mentz
American Heart Journal. 2020-01-01
19 citations
Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observatio...
Michael A. Nauck, Darren K. McGuire, Karen S. Pieper, Yuliya Lokhnygina, Timo E. Strandberg
Cardiovascular Diabetology. 2019-09-03

Advisory Board Member-Editorial Board, New Insights in Obesity: Genetics and Beyond
Advisory Board Member-Editorial Board, Journal of Stem Cell Therapy and Transplantation
Advisory Board Member-Editorial Board, Archives of General Internal Medicine
Advisory Board Member-Editorial Board, Medical Network-Internal Medicine Journal
Advisory Board Member-Editorial Board, International Journal of Hematology and Oncology
Advisory Board Member-Editorial Board, Health And Human Journal
Advisory Board Member-Editorial Board, The New Journal of Medicine
Advisory Board Member-Editorial Board, Bozok Medical Journal
Advisory Board Member-Editorial Board, Ortadogu Medical Journal
Advisory Board Member-Editorial Board, Niche, Journal of Cellular Therapy And Regenerative Medicine